Comment on Fox et al's presentation of two invasive group A streptococcal (GAS) infections.
Zuber D
ZD
Mulla
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use*; D019115:Fasciitis, Necrotizing / Q000382:microbiology*; D017052:Hospital Mortality; D006801:Humans; D010538:Peritonitis / Q000382:microbiology*; D011159:Population Surveillance; D012189:Retrospective Studies; D013290:Streptococcal Infections / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D013297:Streptococcus pyogenes; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002981:Clindamycin